QDEL
QuidelOrtho Corp
Key Financials
Revenue
$2.7B
↓ 1.9%
Total Liabilities
$3.8B
↑ 11.9%
Net Income
$-1131800000
↑ 44.8%
EPS (Diluted)
$-16.69
↑ 45.4%
Cash & Equivalents
$169.8M
↑ 72.7%
Shareholders' Equity
$1.9B
↓ 35.7%
Long-term Debt
$2.7B
↑ 8.4%
Operating Cash Flow
$105.2M
↑ 26.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | QDEL |
| Company Name | QuidelOrtho Corp |
| CIK | 1906324 |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 0101 |
| Phone | (858) 552-1100 |